Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine.
Lamprianidou E, Kordella C, Kazachenka A, Zoulia E, Bernard E, Filia A, Laidou S, Garantziotis P, Vassilakopoulos TP, Papageorgiou SG, Pappa V, Galanopoulos AG, Viniou N, Nakou E, Kalafati L, Chatzidimitriou A, Kassiotis G, Papaemmanuil E, Mitroulis I, Kotsianidis I.
Lamprianidou E, et al. Among authors: filia a.
Blood Adv. 2021 Jan 12;5(1):129-142. doi: 10.1182/bloodadvances.2020002351.
Blood Adv. 2021.
PMID: 33570632
Free PMC article.